New pricing rules lower access barriers for orphan drugs in

A new “flat-rate payment” system may likely be very common for upcoming orphan drugs in France.

Related Keywords

France , French , , Solutions For Pharmaceutical Process Companies , Commission For Economic Evaluation , Public Health Commission , Solid Dose Rx Product Development , French Pharmaceutical Companies Association , Pricing Services , French National Authority For Health Haute Autorit , Translation Services For , Economic Committee , Health Products , Price Intelligence , Therapeutic View , Economic Evaluation , Public Health , French National Authority , Haute Autorit , Life Science , Conveying Solutions , Pharmaceutical Process , Market Access ,